| Issue |
Title |
File |
| Vol 23, No 3 (2023) |
Assessment of fetal resistance to hypoxia using the Stange test as an adjunct to Apgar scale assessment of neonatal health status |
(Rus)
|
|
Shabanov P.D., Urakov A.L., Urakova N.A.
|
| Vol 23, No 3 (2023) |
Analysis of methods for modeling deep defects of the skin and articular cartilage on laboratory animals in the experiment |
(Rus)
|
|
Izbulatov D.D., Varlamova N.V., Mikhailov V.E., Markin I.V., Erdniev A.L., Potapov P.K., Utkin Y.A.
|
| Vol 23, No 2 (2023) |
The molecular mechanisms of drug resistance of glioblastoma. Part 3. Differentiation and apoptosis of glioblastoma cells |
(Rus)
|
|
Chernov A.N., Galimova E.S., Shamova O.V.
|
| Vol 23, No 2 (2023) |
Antimicrobial activity of the complement system |
(Rus)
|
|
Egorova E.V., Krenev I.A., Oborin N.N., Berlov M.N.
|
| Vol 23, No 2 (2023) |
Nonimmune binding of human immunoglobulins G and A by Streptococcus pyogenes: the role of this phenomenon in pathology |
(Eng)
|
|
Burova L.A., Suvorov A.N., Pigarevsky P.V., Totolian A.A.
|
| Vol 23, No 1 (2023) |
The concept of endothelial transcytosis as a theoretical prerequisite for the development of prevention and treatment of atherosclerosis |
(Rus)
|
|
Parfenova N.S., Tanyanskiy D.A.
|
| Vol 23, No 1 (2023) |
Role of the intestinal microbiota in the pathogenesis of multiple sclerosis. Part 2. Gut microbiota as a predisposition factor for the multiple sclerosis development |
(Rus)
(Eng)
|
|
Abdurasulova I.N.
|
| Vol 22, No 4 (2022) |
Interference, syndemia and neutrality of microbiota relationships as components of epidemic self-regulation |
(Rus)
|
|
Sofronov G.A., Belyakov N.A., Boeva E.V.
|
| Vol 22, No 3 (2022) |
Coumarins as a base for the drug development: yes or no? |
(Rus)
|
|
Litasova E.V., Iljin V.V., Myznikov L.V., Brusina M.A., Piotrovskiy L.B.
|
| Vol 22, No 3 (2022) |
Metabolic precursors of nicotinamide adenine dinucleotide and the potential for their clinical use |
(Rus)
|
|
Sutsko I.P., Shlyahtun A.G., Semenenya I.N.
|
| Vol 22, No 3 (2022) |
Renal artery denervation: unsolved questions about mechanisms of changes of systemic hemodynamics |
(Rus)
|
|
Azovtsev R.A., Evlakhov V.I.
|
| Vol 22, No 2 (2022) |
Application of herbal medicinal raw material in complex treatment COVID-19 |
(Rus)
|
|
Khaliullina A.S., Shakirova D.K., Aliullina L.A., Morgatskaya O.V.
|
| Vol 22, No 2 (2022) |
M proteins are the major pathogenicity factors of Streptococcus pyogenes |
(Rus)
|
|
Burova L.A., Suvorov A.N., Totolian A.A.
|
| Vol 22, No 2 (2022) |
Role of the intestinal microbiota in the pathogenesis of multiple sclerosis. Part 1. Clinical and experimental evidence for the involvement of the gut microbiota in the development of multiple sclerosis |
(Rus)
|
|
Abdurasulova I.N.
|
| Vol 22, No 1 (2022) |
Molecular mechanisms of drug resistance of glial tumor of brain. Part 2: Proliferation, angiogenesis, metastasis and recurrency |
(Rus)
|
|
Chernov A.N., Galimova E.S., Shamova O.V.
|
| Vol 22, No 1 (2022) |
Multiple functions of tumor supressor p53 |
(Rus)
|
|
Gudkova A.Y., Antimonova O.I., Shavlovsky M.M.
|
| Vol 22, No 1 (2022) |
Modern understanding of the consequences of lack of sleep |
(Rus)
|
|
Gavrilov Y.V.
|
| Vol 21, No 4 (2021) |
Pathophysiological and genetic mechanisms of migraine |
(Rus)
|
|
Chernov A.N., Galimova E.S.
|
| Vol 21, No 4 (2021) |
Platelets and other cells interactions in the atherosclerosis development |
(Rus)
(Eng)
|
|
Parfenova N.S.
|
| Vol 21, No 4 (2021) |
Molecular mechanisms of drug resistance of glioblastoma part 1: ABC family proteins and inhibitors |
(Rus)
(Eng)
|
|
Chernov A.N., Shamova O.V.
|
| Vol 21, No 3 (2021) |
Analysis of metabolomic and genomic markers for diagnosing cardiovascular diseases |
(Rus)
(Eng)
|
|
Zharkova Z.V., Yasenyavskaya A.L., Nikitina I.B., Goretova I.V., Fedoseev I.V., Bashkina O.А., Samotrueva M.A.
|
| Vol 21, No 3 (2021) |
Infectious complications in patients with chronic lymphocytic leukemia treated with bruton’s tyrosine kinase inhibitors |
(Rus)
|
|
Torshina Y.S., Serebryanaya N.B.
|
| Vol 21, No 2 (2021) |
Inhibition of the complement anaphylatoxin activities in the central nervous system disorders |
(Rus)
(Eng)
|
|
Nekrasova K.A., Ischenko A.M., Trofimov A.V.
|
| Vol 21, No 2 (2021) |
The physicochemical properties and distribution of aluminum in the environment, the effect on living organisms, the reduction of its toxic effect |
(Rus)
(Eng)
|
|
Kutai V.E., Tsygankov V.Y.
|
| Vol 21, No 2 (2021) |
Mast cells and neuroinflammation in pathogenesis of neurologic and psychiatric diseases |
(Rus)
(Eng)
|
|
Grigorev I.P., Korzhevskii D.E.
|
| Vol 21, No 1 (2021) |
Mitral regurgitation followed by acute coronary syndrome |
(Rus)
|
|
Dzeytova A.K., Bolgucheva M.B., Gagieva D.A., Bezieva K.A., Gazdieva L.O.
|
| Vol 21, No 1 (2021) |
Scientific platform, development and implementation of effective immunodiagnosis of tuberculosis infection in the Russian Federation |
(Rus)
|
|
Kudlay D.A.
|
| Vol 21, No 1 (2021) |
The influence of lactoferrin on the epigenetic characteristics of mammalian cells of different types |
(Eng)
|
|
Sharrouf K.A., Suchkova I.O.
|
| Vol 20, No 4 (2020) |
Pathophysiological and age-specific mechanisms of morpho-functional changes in spermatozoa in infertility |
(Eng)
|
|
Dotsenko A.A., Polevshchikov A.V.
|
| Vol 20, No 4 (2020) |
Neutrophilic granulocytes: phagocytes and more |
(Rus)
(Eng)
|
|
Aleshina G.M.
|
| Vol 20, No 3 (2020) |
Genetic engineering approaches to the development of modern therapeutics |
(Rus)
(Eng)
|
|
Bogomolova E.G., Kopeykin P.M., Tagaev A.A.
|
| Vol 20, No 3 (2020) |
Personalized toxicology: phenomenology, relevance, development prospects |
(Rus)
(Eng)
|
|
Rembovskiy V.R., Mogilenkova L.A.
|
| Vol 20, No 3 (2020) |
Covid-19: features of the pathogenesis of the disease and targets for immunotherapeutic effects |
(Rus)
(Eng)
|
|
Klimov N.A., Simbirtsev A.S.
|
| Vol 20, No 1 (2020) |
Diagnostic capabilities of posturological methods in extrapyramidal disorders |
(Rus)
|
|
Kudrevatykh A.V., Miliukhina I.V.
|
| Vol 20, No 1 (2020) |
Potential role of lactoferrin in early diagnostics and treatment of Parkinson disease |
(Eng)
|
|
Sokolov A.V., Miliukhina I.V., Belsky Y.P., Belska N.V., Vasilyev V.B.
|
| Vol 20, No 1 (2020) |
The role of endothelium in atherogenesis: dependence of atherosclerosis development on the properties of vessel endothelium |
(Rus)
|
|
Parfenova N.S.
|
| Vol 20, No 1 (2020) |
Neurodegenerative and metabolic disorders, mediated by the trace amines and their receptors |
(Rus)
|
|
Apryatin S.A., Karpenko M.N., Muruzheva Z.M., Bolshakova M.V., Magazenkova D.N., Klimenko V.M.
|
| Vol 19, No 4 (2019) |
Molecular diagnostics in oncology: new trends |
(Rus)
(Eng)
|
|
Imyanitov E.N.
|
| Vol 19, No 4 (2019) |
Immunohistochemical markers for neurobiology |
(Rus)
(Eng)
|
|
Korzhevskii D.E., Grigor’ev I.P., Gusel’nikova V.V., Kolos E.A., Petrova E.S., Kirik O.V., Sufieva D.A., Razenkova V.A., Antipova M.V., Chernysh M.V.
|
| Vol 19, No 3 (2019) |
Dynamics of age-related structural and functional changes in the brain of patients with autism spectrum disorders |
(Rus)
|
|
Belokoskova S.G., Malsagova E.M., Tsikunov S.G.
|
| Vol 19, No 3 (2019) |
Venous return and pulmonary hemodynamics under the positive end-expiratory pressure mechanical ventilation |
(Rus)
|
|
Evlakhov V.I., Poyassov I.Z.
|
| Vol 19, No 2 (2019) |
The role of cell proliferation in atherogenesis and in the destabilization of atherosclerotic plaque in human |
(Rus)
|
|
Pigarevsky P.V., Yakovleva O.G., Maltseva S.V., Guseva V.A.
|
| Vol 19, No 2 (2019) |
Modern conceptions about the pathogenesis of tumor-related epilepsy |
(Rus)
|
|
Tolstykh N.V., Gurchin A.F., Koroleva N.Y., Stolyarov I.D.
|
| Vol 19, No 2 (2019) |
Role of pancreatic amyloidosis in pathogenesis of type 2 diabetes mellitus |
(Rus)
|
|
Gudkova A.Y., Antimonova O.I., Shavlovsky M.M.
|
| Vol 19, No 1 (2019) |
Lactoferrin as a promising remedy for metabolic syndrome therapy: from molecular mechanisms to clinical trials |
(Rus)
|
|
Elizarova A.Y., Kostevich V.A., Voynova I.V., Sokolov A.V.
|
| Vol 19, No 1 (2019) |
HIV infection, secondary conditions and comorbidities. Part 2. Concomitant diseases |
(Rus)
|
|
Rassokhin V.V., Leonova O.N., Boeva E.V., Stepanova E.V., Belyakov N.A., DiClemente R.
|
| Vol 19, No 1 (2019) |
Modern views on the mechanism of the toxic action of dioxins and their hygienic rationing |
(Rus)
|
|
Sofronov G.A., Rembovskiy V.R., Radilov A.S., Mogilenkova L.A.
|
| Vol 19, No 1 (2019) |
Minimally invasive treatment of spinal compression fractures in multiple myeloma (review) |
(Rus)
|
|
Nagajtseva A.A., Zharikov Y.O.
|
| Vol 19, No 1 (2019) |
Lactoferrin — an endogenous regulator of the protective functions of the organism |
(Rus)
|
|
Aleshina G.M.
|
| 1 - 49 of 49 Items |
|
СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).